The regulation of CBD/Hemp products has been a very hot topic in France these past months since the “Kanavape” ruling. In Kanavape, the CJEU asked France to review its very strict CBD regulations, more specifically its Regulation (arrêté) of 22
Triage Health Law
Triage Health Law, published by Squire Patton Boggs, focuses on legal issues at the intersection of healthcare and competition law. The blog covers topics such as hospital mergers and antitrust implications, regulatory frameworks like Certificates of Public Advantage, enforcement of interlocking directorates under the Clayton Act, and the impact of government actions on healthcare regulatory agencies like the FDA. It also addresses labor market concerns in healthcare, including scrutiny of non-compete agreements and workforce mobility. The blog provides analysis relevant to healthcare providers, insurers, policymakers, and legal counsel navigating complex regulatory and compliance challenges in the healthcare sector.
Latest from Triage Health Law - Page 11
Italian Ministers Announce Timetable for Investment in Digital Health
On January 8, 2022, Minister of Health Roberto Speranza and Minister for Technological Innovation and Digital Transition Vittorio Colao, in an article published in the Italian press, made a number of announcements about the timing of the Italian government’s intended…
AMA and AHA Challenge IDR Process under the No Surprises Act
The American Medical Association and the American Hospital Association filed suit under the Administrative Procedure Act in the District of Columbia District Court challenging portions of the interim final rule (the “Rule”) issued by the Department of Health and Human…
Judge Blocks Portions of Centers for Medicare and Medicaid Services (CMS) Vaccine Mandate (US)
A federal court decision has created a new wrinkle for healthcare employers that are preparing to comply with the new vaccine mandate from the Centers for Medicare and Medicare Services (CMS). On November 29, 2021, Judge Matthew Schelp of…
Healthcare Research: A Transatlantic and Trans-European Dialogue Seminar
On November 23rd, a Squire Patton Boggs partner will lead a panel of industry thought leaders in a discussion of transcontinental health research and data issues. Topics to be explored include:
- What are the challenges that companies need to face
…
COVID-19 Vaccine Mandate Fundamentals for Healthcare Employers
Now that OSHA has issued its emergency temporary standard and CMS has issued its own emergency rule, the landscape has changed once again for healthcare employers in terms of addressing employees’ vaccination status. Fortunately, they now have much more…
OSHA and CMS to Require Employers to Mandate Vaccines or Weekly Negative Tests
The Occupational Safety and Health Administration, as well as the Centers for Medicare & Medicaid Services, are preparing to issue new requirements that will have a major impact on healthcare employers, as well as other employers across the U.S. On…
Ohio’s Pandemic Telemedicine Flexibilities for Physicians Extended to End of 2021
In March 2020, the State Medical Board of Ohio issued guidance temporarily relaxing Ohio’s telemedicine rules for physicians, permitting physicians to use telemedicine in place of in-person visits in many circumstances for the duration of Ohio’s COVID-19 state of emergency…
Will Patents Become More Political? The PTO Begins to Implement Arthrex
In United States v Arthrex, the Supreme Court held that 35 U.S.C. §6(c), which sets forth the authority of Patent Trial & Appeal Board (“PTAB”) Administrative Patent Judges (“APJs”), is unconstitutional because APJs effectively wield the power of principal officers (who…
FDA Revokes EUAs for Certain Non-NIOSH Respirators – A Sign of More to Come?
More than a year after issuing Emergency Use Authorizations (“EUAs”) for filtering facepiece respirators (“FFRs”), surgical masks, and related personal protective equipment (“PPE”), the Food and Drug Administration (“FDA”) is walking back these measures. On June 30, 2021 the FDA…